290 related articles for article (PubMed ID: 20634015)
21. [Preparation and in vitro characterization of apigemin-loaded nanostructured lipid carriers].
Zhai YJ; Guo CY; Hou JN; Zhang WD; Zhai GX
Zhong Yao Cai; 2011 Jun; 34(6):962-5. PubMed ID: 22017012
[TBL] [Abstract][Full Text] [Related]
22. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.
Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW
Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496
[TBL] [Abstract][Full Text] [Related]
23. Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release.
Souza LG; Silva EJ; Martins AL; Mota MF; Braga RC; Lima EM; Valadares MC; Taveira SF; Marreto RN
Eur J Pharm Biopharm; 2011 Sep; 79(1):189-96. PubMed ID: 21352915
[TBL] [Abstract][Full Text] [Related]
24. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
[TBL] [Abstract][Full Text] [Related]
25. Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies.
Martins S; Tho I; Reimold I; Fricker G; Souto E; Ferreira D; Brandl M
Int J Pharm; 2012 Dec; 439(1-2):49-62. PubMed ID: 23046667
[TBL] [Abstract][Full Text] [Related]
26. Stability of lipid excipients in solid lipid nanoparticles.
Radomska-Soukharev A
Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
[TBL] [Abstract][Full Text] [Related]
27. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
Liu CH; Wu CT; Fang JY
Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
[TBL] [Abstract][Full Text] [Related]
28. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles.
Lee MK; Lim SJ; Kim CK
Biomaterials; 2007 Apr; 28(12):2137-46. PubMed ID: 17257668
[TBL] [Abstract][Full Text] [Related]
29. [In vitro dexamethasone release from nanoparticles and its pharmacokinetics in the inner ear after administration of the drug-loaded nanoparticles via the round window].
Chen G; Hou SX; Hu P; Hu QH; Guo DD; Xiao Y
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1022-4. PubMed ID: 18583254
[TBL] [Abstract][Full Text] [Related]
30. Solvent injection-lyophilization of tert-butyl alcohol/water cosolvent systems for the preparation of drug-loaded solid lipid nanoparticles.
Wang T; Wang N; Zhang Y; Shen W; Gao X; Li T
Colloids Surf B Biointerfaces; 2010 Aug; 79(1):254-61. PubMed ID: 20447810
[TBL] [Abstract][Full Text] [Related]
31. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis.
Pradhan M; Singh D; Murthy SN; Singh MR
Steroids; 2015 Sep; 101():56-63. PubMed ID: 26049018
[TBL] [Abstract][Full Text] [Related]
32. The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process.
Yang R; Gao R; Li F; He H; Tang X
Drug Dev Ind Pharm; 2011 Feb; 37(2):139-48. PubMed ID: 20578879
[TBL] [Abstract][Full Text] [Related]
33. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus.
Pople PV; Singh KK
Eur J Pharm Biopharm; 2011 Sep; 79(1):82-94. PubMed ID: 21447390
[TBL] [Abstract][Full Text] [Related]
34. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery.
Shah KA; Date AA; Joshi MD; Patravale VB
Int J Pharm; 2007 Dec; 345(1-2):163-71. PubMed ID: 17644288
[TBL] [Abstract][Full Text] [Related]
35. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.
Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F
Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405
[TBL] [Abstract][Full Text] [Related]
36. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection.
Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY
Eur J Pharm Sci; 2009 Sep; 38(2):138-46. PubMed ID: 19591929
[TBL] [Abstract][Full Text] [Related]
37. Preparation of Coenzyme Q10 nanostructured lipid carriers for epidermal targeting with high-pressure microfluidics technique.
Chen S; Liu W; Wan J; Cheng X; Gu C; Zhou H; Chen S; Zhao X; Tang Y; Yang X
Drug Dev Ind Pharm; 2013 Jan; 39(1):20-8. PubMed ID: 23116283
[TBL] [Abstract][Full Text] [Related]
38. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.
Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S
Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles.
Wong HL; Bendayan R; Rauth AM; Li Y; Wu XY
Adv Drug Deliv Rev; 2007 Jul; 59(6):491-504. PubMed ID: 17532091
[TBL] [Abstract][Full Text] [Related]
40. Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution.
Bondì ML; Craparo EF; Giammona G; Drago F
Nanomedicine (Lond); 2010 Jan; 5(1):25-32. PubMed ID: 20025461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
